CSPI to Convene Forum on Corporate Influence on Federal Advisory Committees on M

[Guest guest]

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)

Promoting Openness, Full Disclosure, and Accountability

http://www.ahrp.org

 

FYI

 

Below is a reminder from the Center for Science in the Public

Interest: On Monday, July 24, a debate about conflicts of interest in

FDA and EPA advisory panels will take place.

 

The public is invited.

 

 

Vera Hassner Sharav

212-595-8974

veracare

 

 

Reminder: This event is free and open to the public.

Contact: For more information, contact Corrie Mauldin, 202-777-8307.

 

Government Science Panels: Fair and Balanced?

CSPI to Convene Forum on Corporate Influence on Federal Advisory

Committees on Monday, July 24

 

The nonprofit Center for Science in the Public Interest will convene

policy makers and scientists from industry and government to discuss

the makeup of the advisory committees that provide science-based

advice to the Food and Drug Administration, the Environmental

Protection Agency, and the federally chartered National Academies.

What: Moderated panel on federal advisory committees, and whether

their members should include representatives who have financial ties

to companies that may have a stake in the proceedings.

 

Who:

 

Moderator: Snigdha Prakash, National Public Radio

 

Frederick R. Anderson, partner, McKenna, Long, & Aldridge, LLP

James Conrad, assistant chief counsel, American Chemistry Council

Merrill Goozner, director, Integrity in Science, CSPI

Dr. Scott Gottlieb, deputy commissioner, FDA

Dr. David Michaels, professor, George Washington University

Dr. Steven Nissen, interim chairman, department of cardiovascular

medicine, Cleveland Clinic Foundation, and former chair, FDA

Cardiovascular and Renal Drugs Advisory Committee

 

When: 1:00 p.m. to 2:30 p.m. EDT on Monday, July 24, 2006

 

Where: National Press Club (Holeman Lounge), 529 14th Street, NW,

Washington, DC

 

Why: Congress is considering legislation that would prohibit the Food

and Drug Administration from appointing scientists with ties to drug

manufacturers to its science advisory panels. The Environmental

Protection Agency routinely appoints such scientists to its

committees, and public interest groups are raising similar concerns

about the National Academy of Sciences. CSPI release a report on the

NAS' practices on this day.